VVUS

VIVUS, Inc. News Headlines

$2.47
*  
0.06
2.37%
Get VVUS Alerts
*Delayed - data as of May 26, 2015  -  Find a broker to begin trading VVUS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By







Arena And Vivus Investors Need To Watch Orexigen
11/10/2014 1:24:00 PM - Seeking Alpha




Belviq Sales Dip Slightly - Quarter Is Flat Thus Far
11/7/2014 1:02:00 PM - Seeking Alpha




Vivus Beats The Street On Milestone Payment For ED Drug
11/6/2014 8:59:00 AM - Seeking Alpha


Will Belviq Advertising Pick Up Again?
11/6/2014 8:55:00 AM - Seeking Alpha












Orexigen Launches Contrave - Watch For Traction
10/20/2014 2:01:00 PM - Seeking Alpha


What To Watch For As Orexigen's Launch Approaches
10/16/2014 8:05:00 AM - Seeking Alpha








Orexigen On A Tear - In The Wrong Direction
10/7/2014 1:10:00 AM - Seeking Alpha


Is VIVUS Inc. a Short Sell?
10/4/2014 1:45:02 PM - Motley Fool




Belviq Sales Benefit From Advertising - Up 2.8%
9/26/2014 12:16:00 PM - Seeking Alpha